194596-99-1

Basic information

• Product Name: Butanoic acid, 3-methyl-3-[[(2,4,6-trimethoxyphenyl)methyl]thio]-
• CAS NO: 194596-99-1
• Molecular Formula: C15H22O5S
• Molecular Weight: 314.403
• Mol File: 194596-99-1.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Butanoic acid, 3-methyl-3-[[(2,4,6-trimethoxyphenyl)methyl]thio]-(CAS DataBase Reference)
• NIST Chemistry Reference: Butanoic acid, 3-methyl-3-[[(2,4,6-trimethoxyphenyl)methyl]thio]-(194596-99-1)
• EPA Substance Registry System: Butanoic acid, 3-methyl-3-[[(2,4,6-trimethoxyphenyl)methyl]thio]-(194596-99-1)

Safety Data

• Hazardous Substances Data: 194596-99-1(Hazardous Substances Data)

Upstream product

• 59729-24-7 3-mercapto-3-methylbutanoic acid 
• 61040-78-6 2,4,6-trimethoxybenzyl alcohol 

Downstream Products

• 474649-92-8 3-methyl-3-(2,4,6-trimethoxy-benzylsulfanyl)-butyric acid 2-benzyloxy-ethyl ester 
• 474649-91-7 3-methyl-3-(2,4,6-trimethoxy-benzylsulfanyl)-butyric acid 3-fluoro-benzyl ester 
• 474649-98-4 3-methyl-3-(2,4,6-trimethoxy-benzylsulfanyl)-butyric acid benzyloxycarbonylmethyl ester 
• 382601-29-8 2'-(2,2,2-trichloroethoxycarbonyl)-7-[3-methyl-3-(2,4,6-trimethoxyphenylmethylsulfanyl)butyryl]paclitaxel 
• 382601-30-1 2'-(2,2,2-trichloroethoxycarbonyl)-7-(3-methyl-3-sulfanylbutyryl)paclitaxel 
• 382601-31-2 C₅₂H₅₉NO₁₅S 

Relevant articles and documents

Combination of Paclitaxel and Nitric Oxide as a Novel Treatment for the Reduction of Restenosis

The combination of a nitric oxide (NO) donor and a paclitaxel-NO donor conjugate coated on a vascular stent was tested in a rabbit iliac artery model of stenosis as a potential therapy for restenosis. Paclitaxel was conjugated with a NO donor at the 7-pos

Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses

The invention provides methods for treating female sexual dysfunctions by administering to a female individual a therapeutically effective amount of at least one compound that donates, transfers or release nitrogen monoxide, that induces the production of

Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use

The present invention describes novel nitrosated and/or nitrosylated phosphodiesterase inhibitors, and novel compositions containing at least one nitrosated and/or nitrosylated phosphodiesterase inhibitor, and, optionally, one or more compounds that donat